The Kay Kendall Leukaemia Fund awards grants for research on aspects of leukaemia and for relevant studies on related haematological malignancies. Applications are sought for first class research on innovative proposals and are particularly welcomed from those with applications close to the care of leukaemia patients or the prevention of leukaemia or related diseases. The Fund also considers support for capital projects that will have direct benefit to leukaemia patient care.
There is a preference to support centres of excellence or those with an established international reputation in the field.
Trustees have recently reviewed and increased the level of support for scientific research. Funding decisions will not be limited by a fixed budget but will be based on the calibre of the applicant, the scientific merit and originality of the proposal and the excellence of the host institution, together with recommendations from peer reviewers and the Trust’s Scientific Advisers.
The Fund is trialling patient care initiatives in selected Strategic Health Authority areas.